Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1069297.RA4enGBxCtkQxpxykMNpp51oVwfFq4sz3vym5__Rb_Eis130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1069297.RA4enGBxCtkQxpxykMNpp51oVwfFq4sz3vym5__Rb_Eis130_assertion type Assertion NP1069297.RA4enGBxCtkQxpxykMNpp51oVwfFq4sz3vym5__Rb_Eis130_head.
- NP1069297.RA4enGBxCtkQxpxykMNpp51oVwfFq4sz3vym5__Rb_Eis130_assertion description "[In obese SHR-cp, compound 11 significantly decreased mean arterial pressure, glucose intolerance, insulin resistance, hypertriglyceridemia, and plasma renin activity with no effect on heart rate, body weight gain, or microalbuminuria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069297.RA4enGBxCtkQxpxykMNpp51oVwfFq4sz3vym5__Rb_Eis130_provenance.
- NP1069297.RA4enGBxCtkQxpxykMNpp51oVwfFq4sz3vym5__Rb_Eis130_assertion evidence source_evidence_literature NP1069297.RA4enGBxCtkQxpxykMNpp51oVwfFq4sz3vym5__Rb_Eis130_provenance.
- NP1069297.RA4enGBxCtkQxpxykMNpp51oVwfFq4sz3vym5__Rb_Eis130_assertion SIO_000772 23586038 NP1069297.RA4enGBxCtkQxpxykMNpp51oVwfFq4sz3vym5__Rb_Eis130_provenance.
- NP1069297.RA4enGBxCtkQxpxykMNpp51oVwfFq4sz3vym5__Rb_Eis130_assertion wasDerivedFrom befree-2016 NP1069297.RA4enGBxCtkQxpxykMNpp51oVwfFq4sz3vym5__Rb_Eis130_provenance.
- NP1069297.RA4enGBxCtkQxpxykMNpp51oVwfFq4sz3vym5__Rb_Eis130_assertion wasGeneratedBy ECO_0000203 NP1069297.RA4enGBxCtkQxpxykMNpp51oVwfFq4sz3vym5__Rb_Eis130_provenance.